889PClinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors. (23rd October 2018)

Record Type:
Journal Article
Title:
889PClinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors. (23rd October 2018)
Main Title:
889PClinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mammalian target of rapamycin inhibitors (mTORI) after immuno-oncology (IO) checkpoint inhibitors
Authors:
Graham, J
Wells, J C
McKay, R
Vaishampayan, U N
Hansen, A
Donskov, F
Bjarnason, G A
Beuselinck, B
De Velasco, G
Duh, M S
Huynh, L
Chang, R
Zanotti, G
Ramaswamy, K
Choueiri, T K
Heng, D Y C
Abstract:
Is Part Of:
Annals of oncology. Volume 29(2018)Supplement 8
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Issue Display:
Volume 29, Issue 8 (2018)
Year:
2018
Volume:
29
Issue:
8
Issue Sort Value:
2018-0029-0008-0000
Page Start:
Page End:
Publication Date:
2018-10-23
Subjects:
Oncology -- Periodicals
616.992
Journal URLs:
https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:
10.1093/annonc/mdy283.098 ↗
Languages:
English
ISSNs:
0923-7534
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
12269.xml